08 February 2026 : Clinical Research
Effect of Duration of Pre-Procedure Fasting on Clinical Outcomes in Intensive Care Patients Undergoing Percutaneous Tracheostomy
Serpil Ekin
BE 1, İlkay Ceylan ADE 1*, Hamide Ayben Korkmaz ADF 1, Gürcan Güler BCD 1, Derful Gülen DEF 1, Buket Özyaprak CEF 1
DOI: 10.12659/MSM.950128
Med Sci Monit 2026; 32:e950128
Table 1 Demographic and baseline clinical characteristics by pre-tracheostomy fasting duration.
| Group 1 (<1 hour)n=92 | Group 2 (1–4 hours)n=72 | Group 3 (5–12 hours)n=47 | Group 4 (>12 hours)n=11 | p | |
|---|---|---|---|---|---|
| 70.7±15.3 | 70.1±15.0 | 70.7±14.3 | 67.9±14.7 | 0.940 | |
| Female, n (%) | 31 (33.7%) | 23 (31.9%) | 22 (46.8%) | 4 (36.4%) | 0.375 |
| Male, n (%) | 61 (66.3%) | 49 (68.1%) | 25 (53.2%) | 7 (63.6%) | 0.375 |
| Multitrauma, n (%) | 8 (8.7%) | 4 (5.6%) | 2 (4.3%) | 0 (0.0%) | 0.566 |
| Cerebrovascular disease, n (%) | 45 (48.9%) | 30 (41.7%) | 18 (38.3%) | 2 (18.2%) | 0.207 |
| Malignancy, n (%) | 5 (5.4%) | 7 (9.7%) | 7 (14.9%) | 2 (18.2%) | 0.227 |
| Pulmonary diseases, n (%) | 20 (21.7%) | 20 (27.8%) | 10 (21.3%) | 4 (36.4%) | 0.593 |
| Cardiac diseases, n (%) | 11 (12.0%) | 6 (8.3%) | 9 (19.1%) | 2 (18.2%) | 0.339 |
| Renal disease, n (%) | 1 (1.1%) | 4 (5.6%) | 0 (0.0%) | 0 (0.0%) | 0.14 |
| Neuromuscular diseases, n (%) | 2 (2.2%) | 1 (1.4%) | 1 (2.1%) | 1 (9.1%) | 0.46 |
| 26.8±7.8 | 25.9±6.4 | 26.2±6.6 | 26.1±3.2 | 0.866 | |
| 1.9±2.0 | 2.2±1.7 | 2.2±1.7 | 2.2±1.8 | 0.733 | |
| n – number; p | |||||